Amylyx Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMLX and other ETFs, options, and stocks.About AMLX
Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia.
AMLX Key Statistics
Stock Snapshot
As of today, Amylyx Pharmaceuticals(AMLX) shares are valued at $18.50. The company's market cap stands at 2.04B, with a P/E ratio of -11.86.
As of 2026-07-09, Amylyx Pharmaceuticals(AMLX) stock has fluctuated between $17.73 and $18.51. The current price stands at $18.50, placing the stock +4.3% above today's low and -0.1% off the high.
The Amylyx Pharmaceuticals(AMLX)'s current trading volume is 929.67K, compared to an average daily volume of 2.09M.
In the last year, Amylyx Pharmaceuticals(AMLX) shares hit a 52-week high of $19.15 and a 52-week low of $6.90.
In the last year, Amylyx Pharmaceuticals(AMLX) shares hit a 52-week high of $19.15 and a 52-week low of $6.90.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.